title: Microbiological findings in febrile neutropenia.
abstract: BACKGROUND
  This study was carried out to assess the isolation rate of bacterial and fungal causative agents in Mexican neutropenic adults with hematological neoplasia.
  
  
  METHODS
  A prospective observational survey involving 120 consecutive episodes of febrile neutropenia during 1 year was carried out. These episodes were observed in 630 patients discharged with diagnoses of leukemia or lymphoma, or after bone-marrow transplantation.
  
  
  RESULTS
  At least one pathogen was isolated in 42 of 120 episodes (35%), and was present in 39 patients with acute myeloid leukemia (AML) (43%), acute lymphoblastic leukemia (ALL) (23%), and in patients who underwent bone-marrow transplantation (20%). Primary bacteremia was the most frequent cause of fever (24 episodes, 57%), followed by intravascular device-related infections (5 episodes, 17%), and soft-tissue infections (5 episodes, 15%). Escherichia coli (33%) was the most frequently isolated agent of primary bacteremia, followed by coagulase-negative Staphylococcus (29%), and Klebsiella oxytoca (16%). Fungal infection was responsible for five events (4%): two episodes of pneumonia (Penicillium marneffei and Aspergillus fumigatus, one event each); two cases of fungemia, one due to Candida tropicalis and one to Rhodotorula gluttinis, and one cryptococcal meningitis event.
  
  
  CONCLUSIONS
  The isolation rate, approximately 30%, was in accordance with previous reports; similar percentages of Gram-positive and Gram-negative isolates were found. A remarkably low rate of viridans group streptococci and fungal agents was observed, despite the fact that neutropenia is the main risk factor for infection due to these agents. Studies reporting local microbiological findings are necessary because they support an antibiotic choice for prophylaxis or therapy more accurately than reports from other areas.
authors.affiliation: Departamento de Infectología, Hospital de Infectología, México, D. F., Mexico.
authors.forename: J
authors.initials: J
authors.lastname: Gaytán-Martínez
authors.forename: E
authors.initials: E
authors.lastname: Mateos-García
authors.forename: E
authors.initials: E
authors.lastname: Sánchez-Cortés
authors.forename: J
authors.initials: J
authors.lastname: González-Llaven
authors.forename: L J
authors.initials: LJ
authors.lastname: Casanova-Cardiel
authors.forename: J L
authors.initials: JL
authors.lastname: Fuentes-Allen
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D016470:Bacteremia / Q000150:complications / Q000382:microbiology* / Q000503:physiopathology; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D005260:Female; D005334:Fever / Q000382:microbiology*; D006090:Gram-Negative Bacteria / Q000187:drug effects / Q000302:isolation & purification; D006094:Gram-Positive Bacteria / Q000187:drug effects / Q000302:isolation & purification; D006801:Humans; D007945:Leukemia, Lymphoid / Q000150:complications / Q000382:microbiology* / Q000503:physiopathology; D007951:Leukemia, Myeloid / Q000150:complications / Q000382:microbiology* / Q000503:physiopathology; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D009503:Neutropenia / Q000382:microbiology*; D011446:Prospective Studies
chemical_list: D000900:Anti-Bacterial Agents